한글목차

세계 알코올 사용 장애 치료 시장 전망은 병원 및 클리닉 시장에서의 기회로 인해 유망합니다. 세계 알코올 사용 장애 치료 시장은 2025-2031년 6.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 알코올 사용 장애에 대한 인식 증가, 효과적인 치료 프로그램에 대한 수요 증가, 외래 재활 서비스 채택 확대 등입니다.

• Lucintel의 예측에 따르면, 유형별로는 치료가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 병원이 높은 성장이 예상됩니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.

알코올 사용 장애 치료 시장의 새로운 트렌드

새로운 트렌드는 개인화, 편의성, 기술 기반 솔루션에 초점을 맞추어 알코올 사용 장애 치료 시장을 재편하고 있습니다. 이러한 추세는 보다 효과적인 치료, 환자와의 더 나은 관계, 접근성 향상과 같은 요구에 대한 직접적인 반응입니다. 이러한 추세는 치료가 획일적인 접근이 아닌 고도로 맞춤화된 지속적인 여정이 되는 미래로 시장을 움직이고 있습니다.

• 디지털 텔레헬스 솔루션: 중요한 트렌드는 AUD 치료를 위한 디지털 플랫폼, 모바일 앱, 원격 의료의 채택이 증가하고 있다는 점입니다. 특히 서비스가 충분하지 않은 지역이나 농어촌 지역에서는 접근성과 편의성이 향상되고 있습니다. 이러한 추세는 환자에게 원격 상담, 모니터링 및 지원을 제공하고, 치료 순응도를 향상시키고, 치료에 대한 지리적 장벽을 극복할 수 있습니다.
• 맞춤의료와 유전학: 이 시장에서는 환자의 유전자 프로파일과 바이오마커를 기반으로 치료를 맞춤화하는 맞춤의료에 대한 추세를 볼 수 있습니다. 그 결과, 보다 효과적이고 타겟팅된 치료가 가능해집니다. 약물 치료에 대한 환자별 반응을 이해하면 임상의는 최적의 약물과 용량을 선택할 수 있어 더 나은 결과와 장기적인 회복 가능성을 높일 수 있습니다.
• 신규 치료제 개발: 다양한 작용기전을 가진 새로운 약리학적 치료제가 개발되는 추세입니다. 그 영향은 기존 약물 치료에 반응하지 않는 환자들을 위한 치료 옵션의 확대입니다. 이 신약들은 갈망과 재발 등 AUD의 다양한 측면을 다루도록 설계되어 보다 종합적인 접근법을 통해 AUD를 관리할 수 있도록 합니다.
• 행동치료의 통합: 시장에서는 인지행동치료(CBT)와 같은 행동치료와 약물 치료의 통합이 진행되고 있습니다. 그 영향은 보다 총체적이고 효과적인 치료 모델이 되고 있습니다. 이러한 복합적 접근은 AUD의 생물학적 측면과 심리적 측면을 모두 다루며, 환자의 정착률 향상과 장기적인 회복의 성공으로 이어집니다.
• 약물 보조 치료의 중요성: 중요한 추세는 약물요법(MAT)의 중요성이 강조되고 있다는 점입니다. 그 영향은 환자의 예후가 크게 개선되고 재발률이 감소하는 것입니다. 약물 치료에 상담과 행동치료를 결합한 MAT는 현재 AUD의 표준치료로 널리 인정받고 있으며, 의료기관에서도 적극적으로 추진하고 있습니다.

이러한 새로운 트렌드는 알코올 사용 장애 치료 시장을 보다 유연하고 접근성이 용이하며 환자 중심의 치료 모델로 변화시킴으로써 알코올 사용 장애 치료 시장을 근본적으로 재구성하고 있습니다. 초점은 일회성 개입에서 기술과 표적 치료를 활용하여 결과를 개선하고 장애의 사회적 부담을 줄이기 위한 지속적이고 맞춤 치료 여정으로 이동하고 있습니다.

알코올 사용 장애 치료 시장의 최근 동향

최근 알코올 사용 장애 치료 시장의 트렌드는 혁신적인 치료법과 새로운 제공 방식을 통해 환자의 치료 결과를 개선하고 치료 접근성을 확대하는 데 초점을 맞추었습니다. 이러한 개발은 낮은 치료율과 높은 재발률이라는 고질적인 문제에 대한 직접적인 대응입니다. 그 목표는 치료를 더 효과적이고 편리하게 만들고, 낙인을 없애고, 더 많은 사람들이 도움을 요청할 수 있도록 하는 것입니다.

• 경구용 예방약 출시: 중요한 개발은 알코올 재발을 장기적으로 예방할 수 있는 새로운 경구용 약품의 출시입니다. 그 효과는 환자의 순응도 향상과 음주 에피소드의 감소입니다. 서방형 나트렉손과 같은 이러한 약물은 욕구를 관리하고 장기적인 회복에 필수적인 재발을 예방할 수 있는 편리하고 효과적인 방법을 제공합니다.
• 디지털 치료제의 발전: 주요 발전은 처방에 의한 디지털 치료제(PDT)의 승인과 사용 확대입니다. 이 영향은 증거에 기반한 행동 치료를 제공하기 위한 접근하기 쉬운 새로운 도구입니다. 모바일 앱이나 온라인 프로그램과 같은 PDT는 환자가 인지행동치료 및 기타 지원을 단독으로 또는 기존 치료의 보조 수단으로 유연하고 편리하게 받을 수 있는 방법을 제공합니다.
• 원격의료와 원격진료의 부상: 최근 시장 개척에서 원격의료는 AUD 치료에 광범위하게 채택되고 있습니다. 특히 농촌 지역이나 의료 혜택이 충분하지 않은 지역에서는 접근 편의성이 향상되고 있습니다. 원격 의료를 통해 환자는 집에서 의료 전문가와 상담하고 치료 세션에 참여할 수 있어 편견을 없애고 지리적 장벽을 극복하는 데 도움이 됩니다.
• 정신치료 파이프라인: 최근 AUD에 대한 환각 보조요법 연구 파이프라인이 확대되고 있습니다. 그 영향은 치료의 패러다임 전환이 될 수 있으며, 중독의 근본적인 심리적 문제를 해결할 수 있는 새로운 접근법을 제공할 수 있습니다. 아직 임상 초기 단계이지만, 이러한 치료법은 환자들이 AUD에서 장기적인 관해 상태를 유지하는 데 도움이 될 것으로 기대되고 있습니다.
• 동반질환에 대한 관심 증가: 주요 발전으로 AUD와 동시에 우울증, 불안장애 등 정신질환이 동반되는 것을 인식하고 치료에 초점을 맞추게 된 것을 들 수 있습니다. 그 결과, 많은 환자들에게 보다 종합적이고 효과적인 치료가 가능해졌습니다. 이 통합적 접근법은 중독의 복잡한 성격을 다루고 환자의 전반적인 건강과 웰빙을 향상시킵니다.

이러한 발전은 보다 현대적이고 통합적인 치료 모델로의 전환을 가속화하고 알코올 사용 장애 치료 시장에 큰 영향을 미치고 있습니다. 새로운 치료 옵션, 디지털 기술, 환자 건강에 대한 종합적인 접근 방식에 대한 관심은 시장 성장을 가속할 뿐만 아니라 AUD로 고통받는 사람들에게 새로운 희망을 가져다주고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 알코올 사용 장애 치료 시장 : 유형별

• 개요
• 매력 분석 : 유형별
• 의약품 : 동향과 예측(2019년-2031년)
• 테라피 : 동향과 예측(2019년-2031년)
• 다학제적 치료 : 동향과 예측(2019년-2031년)

제5장 세계의 알코올 사용 장애 치료 시장 : 용도별

• 개요
• 매력 분석 : 용도별
• 병원 : 동향과 예측(2019년-2031년)
• 클리닉 : 동향과 예측(2019년-2031년)

제6장 지역 분석

• 개요
• 세계의 알코올 사용 장애 치료 시장 : 지역별

제7장 북미의 알코올 사용 장애 치료 시장

• 개요
• 북미 알코올 사용 장애 치료 시장 : 유형별
• 북미 알코올 사용 장애 치료 시장 : 용도별
• 미국 알코올 사용 장애 치료 시장
• 멕시코 알코올 사용 장애 치료 시장
• 캐나다 알코올 사용 장애 치료 시장

제8장 유럽의 알코올 사용 장애 치료 시장

• 개요
• 유럽 알코올 사용 장애 치료 시장 : 유형별
• 유럽 알코올 사용 장애 치료 시장 : 용도별
• 독일 알코올 사용 장애 치료 시장
• 프랑스 알코올 사용 장애 치료 시장
• 스페인 알코올 사용 장애 치료 시장
• 이탈리아 알코올 사용 장애 치료 시장
• 영국 알코올 사용 장애 치료 시장

제9장 아시아태평양의 알코올 사용 장애 치료 시장

• 개요
• 아시아태평양 알코올 사용 장애 치료 시장 : 유형별
• 아시아태평양 알코올 사용 장애 치료 시장 : 용도별
• 일본 알코올 사용 장애 치료 시장
• 인도 알코올 사용 장애 치료 시장
• 중국 알코올 사용 장애 치료 시장
• 한국 알코올 사용 장애 치료 시장
• 인도네시아 알코올 사용 장애 치료 시장

제10장 기타 지역의 알코올 사용 장애 치료 시장

• 개요
• 기타 지역 알코올 사용 장애 치료 시장 : 유형별
• 기타 지역 알코올 사용 장애 치료 시장 : 용도별
• 중동 알코올 사용 장애 치료 시장
• 남미 알코올 사용 장애 치료 시장
• 아프리카 알코올 사용 장애 치료 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 성장 기회 : 유형별
  • 성장 기회 : 용도별
• 세계 알코올 사용 장애 치료 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 합병, 인수, 계약, 제휴 및 합작투자(JV)

제13장 밸류체인 전체 주요 기업 개요

• Competitive Analysis
• Alkermes
• Teva Pharmaceutical Industries
• BioCorRx
• Adial Pharmaceuticals
• Addex Therapeutics
• Kinnov Therapeutics
• Opiant Pharmaceuticals
• Omeros Corporation
• GlaxoSmithKline
• Merck & Co.

제14장 부록

• 도표
• 표 리스트
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel에 대해
• 문의

영문목차

The future of the global alcohol use disorder treatment market looks promising with opportunities in the hospital and clinic markets. The global alcohol use disorder treatment market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing awareness about alcohol use disorder, the rising demand for effective treatment programs, and the growing adoption of outpatient rehabilitation services.

• Lucintel forecasts that, within the type category, therapy is expected to witness the highest growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Alcohol Use Disorder Treatment Market

Emerging trends are reshaping the alcohol use disorder treatment market by focusing on personalized, convenient, and technologically-driven solutions. These trends are a direct response to the need for more effective treatments, better patient engagement, and improved accessibility. They are moving the market towards a future where treatment is not a one-size-fits-all approach but a highly tailored and continuous journey.

• Digital & Telehealth Solutions: A key trend is the increasing adoption of digital platforms, mobile apps, and telehealth for AUD treatment. The impact is enhanced accessibility and convenience, particularly in underserved and rural areas. This trend provides patients with remote counseling, monitoring, and support, which can improve treatment adherence and overcome geographical barriers to care.
• Personalized Medicine & Genetics: The market is seeing a trend toward personalized medicine, where treatment is tailored based on a patient's genetic profile and biomarkers. The impact is more effective and targeted therapies. By understanding an individual's unique response to medication, clinicians can select the most suitable drug and dosage, leading to better outcomes and a higher chance of long-term recovery.
• Development of Novel Therapeutics: There is a trend toward the development of novel pharmacological therapies with different mechanisms of action. The impact is an expansion of treatment options for patients who do not respond to existing medications. These new drugs are being designed to address various aspects of AUD, such as craving and relapse, offering a more comprehensive approach to management.
• Integration of Behavioral Therapies: The market is increasingly integrating behavioral therapies, like Cognitive Behavioral Therapy (CBT), with pharmacotherapies. The impact is a more holistic and effective treatment model. This combined approach addresses both the biological and psychological aspects of AUD, leading to improved patient retention and more successful long-term recovery.
• Focus on Medication-Assisted Treatment: A key trend is the increased emphasis on medication-assisted treatment (MAT). The impact is a significant improvement in patient outcomes and a reduction in relapse rates. MAT, which combines medication with counseling and behavioral therapies, is now widely recognized as the gold standard of care for AUD and is being actively promoted by health organizations.

These emerging trends are fundamentally reshaping the alcohol use disorder treatment market by transforming it into a more flexible, accessible, and patient-centric model of care. The focus has shifted from a one-time intervention to a continuous, personalized treatment journey that leverages technology and targeted therapies to improve outcomes and reduce the societal burden of the disorder.

Recent Developments in the Alcohol Use Disorder Treatment Market

Recent developments in the alcohol use disorder treatment market are focused on improving patient outcomes and expanding access to care through innovative therapies and new delivery methods. These developments are a direct response to the persistent challenges of low treatment rates and high relapse numbers. The goal is to make treatment more effective, convenient, and less stigmatizing, thereby encouraging more people to seek help.

• Launch of Oral Prophylactic Medications: A significant development is the launch of new oral medications designed for long-term prophylaxis against alcohol relapse. The impact is greater patient adherence and a reduction in drinking episodes. These medications, such as extended-release naltrexone, offer a convenient and effective way to manage cravings and prevent relapse, which is crucial for long-term recovery.
• Advancements in Digital Therapeutics: A key development is the growing approval and use of prescription digital therapeutics (PDTs). The impact is a new, accessible tool for delivering evidence-based behavioral therapies. PDTs, such as mobile apps and online programs, offer a flexible and convenient way for patients to receive cognitive behavioral therapy and other support, either as a standalone treatment or as an adjunct to traditional care.
• Rise of Telemedicine and Remote Care: The market has seen a recent development in the widespread adoption of telemedicine for AUD treatment. The impact is enhanced accessibility, particularly in rural and underserved areas. Telemedicine allows patients to consult with healthcare professionals and attend therapy sessions from the comfort of their homes, which helps to reduce stigma and overcome geographical barriers.
• Pipeline of Psychedelic-Assisted Therapies: Recent developments include a growing pipeline of research into psychedelic-assisted therapies for AUD. The impact is a potential paradigm shift in treatment, offering a new approach to address the underlying psychological issues of addiction. While still in early clinical stages, these therapies show promise in helping patients achieve long-lasting remission from AUD.
• Increased Focus on Comorbidity: A key development is the increased recognition and focus on treating co-occurring mental health disorders, such as depression and anxiety, alongside AUD. The impact is a more holistic and effective treatment for many patients. This integrated approach addresses the complex nature of addiction and improves overall patient health and well-being.

These developments are having a profound impact on the alcohol use disorder treatment market by accelerating the transition to a more modern and integrated model of care. The focus on new therapeutic options, digital technology, and a holistic approach to patient health is not only driving market growth but also offering new hope for individuals struggling with AUD.

Strategic Growth Opportunities in the Alcohol Use Disorder Treatment Market

Strategic growth opportunities in the alcohol use disorder treatment market are concentrated on expanding the use of these therapies across a wider patient population and for different stages of the disorder. These opportunities are driven by the modernization of healthcare systems, the increasing use of technology, and a growing emphasis on preventive care. The focus is on leveraging innovation to address unmet clinical needs and improve access to care.

• Outpatient and Ambulatory Settings: The greatest growth opportunity lies in providing AUD treatment in outpatient and ambulatory settings. The impact is a wider reach and increased patient convenience. As patients prefer to receive care without disrupting their daily lives, offering medication-assisted treatment and behavioral therapies in these settings can significantly boost market penetration and patient retention.
• Digital Therapeutics for Mild-to-Moderate AUD: A key strategic opportunity is targeting patients with mild-to-moderate AUD with digital therapeutics. The impact is a significant expansion of the patient base. These solutions can be a low-cost, low-stigma entry point for individuals who may be hesitant to seek traditional, in-person treatment, and can provide effective early intervention.
• Combination Therapies for Severe Cases: There is a growth opportunity in developing and promoting combination therapies for severe AUD cases. The impact is enhanced efficacy and a more comprehensive approach to care. Combining pharmacological treatments with intensive behavioral therapies can address the complex needs of patients with severe addiction, leading to better long-term outcomes and a reduction in relapse.
• Treatment for Specific Subpopulations: The market has a strategic opportunity in developing tailored treatments for specific subpopulations, such as adolescents, women, and individuals with co-occurring mental health disorders. The impact is a more personalized and effective care model. These specialized programs can address the unique challenges and needs of these groups, leading to higher success rates.
• Expansion into Corporate Wellness Programs: A promising growth opportunity is integrating AUD treatment and screening into corporate wellness and employee assistance programs. The impact is a reduction in workplace productivity loss and healthcare costs. By providing a confidential and accessible way for employees to seek help, companies can address AUD proactively and support a healthier workforce.

These strategic growth opportunities are reshaping the alcohol use disorder treatment market by diversifying its applications and integrating it into a broader healthcare and wellness landscape. The focus on new patient populations, convenient delivery methods, and preventive care is driving market innovation and positioning AUD treatment as a critical area of growth in modern medicine.

Alcohol Use Disorder Treatment Market Driver and Challenges

Major drivers and challenges impacting the alcohol use disorder treatment market are a complex interplay of technological, economic, and regulatory factors. These forces are influencing market growth and shaping the competitive landscape. While the increasing prevalence of the disease and a growing recognition of it as a medical condition are propelling the market forward, issues related to stigma, high costs, and a lack of access pose significant hurdles.

The factors responsible for driving the alcohol use disorder treatment market include:

1. Rising Prevalence of Alcohol Use Disorder: The increasing global prevalence of AUD is a primary market driver. This growing patient pool creates a pressing need for effective therapeutic solutions, fueling research and development efforts and ensuring a sustained demand for a wide range of treatments to manage the disease.

2. Technological Advancements in Digital Health: Significant advancements in digital health and telemedicine are a major driver. These technologies are making AUD treatment more accessible and convenient, particularly for individuals in rural or underserved areas, which is helping to bridge the gap between those who need treatment and those who receive it.

3. Growing Awareness and Destigmatization: A global shift in perception that views AUD as a medical condition rather than a moral failing is a key driver. This growing awareness reduces the stigma associated with addiction, encouraging more people to seek help and increasing the demand for treatment services and medications.

4. Development of Novel Medications: The continuous development and approval of new pharmacological therapies with improved efficacy and safety profiles are driving market growth. These novel drugs provide clinicians with a wider array of tools to treat AUD, particularly for patients who do not respond to existing medications.

5. Government Initiatives and Funding: Favorable government policies and increased funding for mental health and addiction treatment are a key driver. These initiatives, such as grants for research and expansion of treatment centers, are helping to build the necessary infrastructure and support services to meet the growing demand for AUD care.

Challenges in the alcohol use disorder treatment market are:

1. Stigma and Social Barriers: The persistent social stigma associated with AUD is a major challenge. Many individuals with AUD are hesitant to seek help due to fear of judgment from family, friends, and employers, which results in a large, unaddressed patient population and limits the market's full potential.

2. High Cost of Treatment: The significant cost of comprehensive AUD treatment, including residential programs and long-term medication, is a major challenge. This financial barrier can limit access to care for many individuals, particularly those without adequate insurance coverage, and can lead to higher dropout rates from treatment programs.

3. Lack of Access in Underserved Areas: A key challenge is the lack of specialized AUD treatment facilities and healthcare professionals in rural and underserved areas. This geographical disparity limits access to care for a significant portion of the population, which highlights the need for more telemedicine solutions and community-based programs.

The overall impact of these drivers and challenges is a market that is expanding, but with significant constraints. While the demand for effective therapies and a robust pipeline are creating a strong impetus for growth, issues of stigma, cost, and access are creating a competitive and sometimes restrictive environment. The market's future will depend on its ability to produce more affordable, accessible, and destigmatized products to overcome these hurdles.

List of Alcohol Use Disorder Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies alcohol use disorder treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the alcohol use disorder treatment companies profiled in this report include-

• Alkermes
• Teva Pharmaceutical Industries
• BioCorRx
• Adial Pharmaceuticals
• Addex Therapeutics
• Kinnov Therapeutics
• Opiant Pharmaceuticals
• Omeros Corporation
• GlaxoSmithKline
• Merck & Co.

Alcohol Use Disorder Treatment Market by Segment

The study includes a forecast for the global alcohol use disorder treatment market by type, application, and region.

Alcohol Use Disorder Treatment Market by Type [Value from 2019 to 2031]:

• Medication
• Therapy
• Multidisciplinary Treatment

Alcohol Use Disorder Treatment Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic

Country Wise Outlook for the Alcohol Use Disorder Treatment Market

The alcohol use disorder treatment market is undergoing a significant transformation, driven by a global shift towards a more comprehensive and accessible approach to care. This evolution is marked by the development of novel pharmaceuticals, the integration of digital health solutions, and a growing recognition of AUD as a chronic medical condition. The market is moving beyond traditional rehabilitation models to offer a wider range of patient-centric therapies.

• United States: The U.S. market is dominant, fueled by high AUD prevalence and a robust healthcare infrastructure. Recent developments include the approval of new medications and a significant push for digital therapeutics. Telehealth and remote monitoring are also gaining traction, enhancing accessibility for patients in rural areas and those with limited mobility, thus addressing the persistent treatment gap.
• China: The Chinese market is in an early growth phase, with developments focused on increasing awareness and establishing treatment infrastructure. While traditional Chinese medicine is prevalent, there is a growing interest in Western pharmacological therapies. Government initiatives to address mental health and substance abuse are gradually expanding, creating a foundation for future market growth.
• Germany: In Germany, the market is characterized by a well-established healthcare system and a focus on integrating pharmacological and behavioral therapies. Recent developments include a greater emphasis on personalized medicine, with treatments tailored to individual genetic profiles. The market is also seeing a push for more comprehensive care models that combine medication, counseling, and long-term support.
• India: The Indian market is growing steadily, driven by rising AUD prevalence and government initiatives. Recent developments include the establishment of more rehabilitation centers and the increased use of telemedicine to reach underserved populations. Public awareness campaigns and support from key organizations are helping to reduce the stigma associated with addiction, encouraging more people to seek help.
• Japan: Japan's market is technologically advanced and is addressing AUD in an aging population. Developments are focused on the approval of new, effective, and tolerable pharmacological therapies, as existing drugs often have limited efficacy. The government is also increasing funding for mental health, and there's a growing demand for novel treatments to combat the rising societal challenges posed by alcohol misuse.

Features of the Global Alcohol Use Disorder Treatment Market

• Market Size Estimates: Alcohol use disorder treatment market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Alcohol use disorder treatment market size by type, application, and region in terms of value ($B).
• Regional Analysis: Alcohol use disorder treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the alcohol use disorder treatment market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the alcohol use disorder treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the alcohol use disorder treatment market by type (medication, therapy, and multidisciplinary treatment), application (hospital and clinic), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Alcohol Use Disorder Treatment Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Medication: Trends and Forecast (2019-2031)
• 4.4 Therapy: Trends and Forecast (2019-2031)
• 4.5 Multidisciplinary Treatment: Trends and Forecast (2019-2031)

5. Global Alcohol Use Disorder Treatment Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital: Trends and Forecast (2019-2031)
• 5.4 Clinic: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Alcohol Use Disorder Treatment Market by Region

7. North American Alcohol Use Disorder Treatment Market

• 7.1 Overview
• 7.2 North American Alcohol Use Disorder Treatment Market by Type
• 7.3 North American Alcohol Use Disorder Treatment Market by Application
• 7.4 United States Alcohol Use Disorder Treatment Market
• 7.5 Mexican Alcohol Use Disorder Treatment Market
• 7.6 Canadian Alcohol Use Disorder Treatment Market

8. European Alcohol Use Disorder Treatment Market

• 8.1 Overview
• 8.2 European Alcohol Use Disorder Treatment Market by Type
• 8.3 European Alcohol Use Disorder Treatment Market by Application
• 8.4 German Alcohol Use Disorder Treatment Market
• 8.5 French Alcohol Use Disorder Treatment Market
• 8.6 Spanish Alcohol Use Disorder Treatment Market
• 8.7 Italian Alcohol Use Disorder Treatment Market
• 8.8 United Kingdom Alcohol Use Disorder Treatment Market

9. APAC Alcohol Use Disorder Treatment Market

• 9.1 Overview
• 9.2 APAC Alcohol Use Disorder Treatment Market by Type
• 9.3 APAC Alcohol Use Disorder Treatment Market by Application
• 9.4 Japanese Alcohol Use Disorder Treatment Market
• 9.5 Indian Alcohol Use Disorder Treatment Market
• 9.6 Chinese Alcohol Use Disorder Treatment Market
• 9.7 South Korean Alcohol Use Disorder Treatment Market
• 9.8 Indonesian Alcohol Use Disorder Treatment Market

10. ROW Alcohol Use Disorder Treatment Market

• 10.1 Overview
• 10.2 ROW Alcohol Use Disorder Treatment Market by Type
• 10.3 ROW Alcohol Use Disorder Treatment Market by Application
• 10.4 Middle Eastern Alcohol Use Disorder Treatment Market
• 10.5 South American Alcohol Use Disorder Treatment Market
• 10.6 African Alcohol Use Disorder Treatment Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Alcohol Use Disorder Treatment Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Alkermes
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Teva Pharmaceutical Industries
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 BioCorRx
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Adial Pharmaceuticals
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Addex Therapeutics
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Kinnov Therapeutics
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Opiant Pharmaceuticals
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Omeros Corporation
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 GlaxoSmithKline
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Merck & Co.
  • Company Overview
  • Alcohol Use Disorder Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us